86.90.E - Other human health activities notelsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
68.20.Z - Rental and operating of own or leased real estate
85 - Education
86 - Human health activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 40,5 | 78,9 | 11,2 | -85,8 |
EBITDA | 51,8 | 90,2 | 25 | -72,2 |
Short time liabilities | 922,9 | 93,8 | 870,3 | 828,3 |
Equity capital | -790,3 | -711,4 | -700,2 | 1,6 |
Operating profit (EBIT) | 40,5 | 78,9 | 13,8 | -82,5 |
Assets | 132,6 | 180,5 | 170,2 | -5,7 |
Net profit (loss) | 40,5 | 78,9 | 11,2 | -85,8 |
Cash | 16,8 | 17,7 | 1,7 | -90,3 |
Net income from sale | 389,6 | 491,8 | 115,3 | -76,6 |
Liabilities and provisions for liabilities | 922,9 | 891,9 | 870,3 | -2,4 |
Working assets | 109,2 | 168,3 | 169,2 | 0,5 |
Depreciation | 11,3 | 11,3 | 11,3 | 0 |
% | % | % | p.p. | |
Profitability of capital | -5,1 | -11,1 | -1,6 | 9,5 |
Equity capital to total assets | -595,8 | -394,1 | -411,5 | -17,4 |
Gross profit margin | 10,4 | 16 | 9,7 | -6,3 |
EBITDA Margin | 13,3 | 18,3 | 21,7 | 3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 865 | 70 | 2755 | 2685 |
Current financial liquidity indicator | 0.11832648515701294 | 1.7951728105545044 | 0.19443431496620178 | -1,6 |
Net dept to EBITDA | 14.898136138916016 | 8.654057502746582 | 32.79021072387695 | 24,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane